Accurate measurement of serum creatinine is essential for the correct estimation of glomerular filtration rate (eGFR) and, consequently, adequate classification of the presence of chronic kidney disease (CKD). The variability in serum creatinine test results among medical laboratories and manufacturers has greatly been reduced since the development and availability of NIST SRM 967 and NIST SRM 967a and the rapid adoption of these matrix-based reference materials for standardizing creatinine tests to SI units [1] . However, standardization of calibration does not eradicate analytical interferences by non-creatinine chromogens such as ketones, glucose and proteins [1] [2] [3] [4] . Using data from the Dutch external quality assessment (EQA) organization SKML, we demonstrated that Jaffe techniques overestimate serum creatinine values, leading to substantial misclassification of patients into a lower CKD category [2] . In addition, when, more recently, frozen commutable samples were circulated to 89 laboratories in four European countries, Jaffe methods still showed unsatisfactory performance in terms of bias, imprecision and specificity, particularly when the samples were spiked with glucose [1]. These problems were not encountered with specific enzymatic methods [1] [2] [3] [4] .
To the Editor, Accurate measurement of serum creatinine is essential for the correct estimation of glomerular filtration rate (eGFR) and, consequently, adequate classification of the presence of chronic kidney disease (CKD). The variability in serum creatinine test results among medical laboratories and manufacturers has greatly been reduced since the development and availability of NIST SRM 967 and NIST SRM 967a and the rapid adoption of these matrix-based reference materials for standardizing creatinine tests to SI units [1] . However, standardization of calibration does not eradicate analytical interferences by non-creatinine chromogens such as ketones, glucose and proteins [1] [2] [3] [4] . Using data from the Dutch external quality assessment (EQA) organization SKML, we demonstrated that Jaffe techniques overestimate serum creatinine values, leading to substantial misclassification of patients into a lower CKD category [2] . In addition, when, more recently, frozen commutable samples were circulated to 89 laboratories in four European countries, Jaffe methods still showed unsatisfactory performance in terms of bias, imprecision and specificity, particularly when the samples were spiked with glucose [1] . These problems were not encountered with specific enzymatic methods [1] [2] [3] [4] .
The results of the previous study were criticized because modified (non-native) patient samples were used. Therefore, we here illustrate the degree of interference by glucose and total protein on serum creatinine measurements and eGFR (CKD-EPI) calculations using the Jaffe and enzymatic techniques in fresh patient samples. The measurements were performed according to the manufacturers' instructions. In all laboratories, the samples were measured in a standardized order in one e186 den Elzen et al.: Glucose and total protein: unacceptable interference on Jaffe creatinine assays batch. In addition, two IDMS-RMP targeted calibrators were measured eight times for each method. The means of these calibrator measurements were plotted against the target calibrator values. The estimated deviations from the target calibrator values were used to adjust the patient results, generating IDMS traceable creatinine measurements and eliminating differences in calibration between methods. Because enzymatic methods have been shown to be insensitive to interfering substances [4] , the target values of the patient samples were defined as the mean of the IDMS traceable patient results of the four enzymatic methods. This approach was supported by a verification experiment in which all laboratories measured 10 IDMS targeted EQA samples, showing (a) exchangeable results for the four enzymatic methods and (b) no substantial bias compared to the target values (data not shown).
The results are summarized in Tables 1 and 2 . When creatinine was measured with enzymatic methods, no interference was observed in samples with low or high total protein concentrations, or in samples with normal or high glucose concentrations (Table 1) . By contrast, when, for example, using the Jaffe method on the Abbott platform, a negative bias of −6 μmol/L was found in samples with a low total protein concentration (50 g/L), and a positive bias of +4 μmol/L was found in samples with a high total protein concentration (80 g/L). In addition, a positive bias of +33 μmol/L was observed for samples with a high glucose concentration (30 mmol/L). Similar results were obtained when samples were measured using the Jaffe method on the Beckman-Coulter, Roche and Siemens platforms. As is illustrated in Table 2 , these biases in creatinine outcomes using Jaffe methods lead to incorrect eGFR calculations on all platforms, ranging from severe overestimations (>20% above the actual eGFR) in case of low total protein (30 g/L) and low glucose (0-5 mmol/L) concentrations or underestimations (>30% below the actual eGFR) in case of high protein (100 g/L) and high glucose (30 mmol/L) concentrations.
Because CKD staging directly relies on eGFR calculations [2] , the observed systematic errors in creatinine measurements using the Jaffe method and subsequent incorrect eGFR calculations have an unacceptable impact on CKD patient care with respect to diagnosis, prognosis, follow-up and treatment. Despite earlier efforts to abandon Jaffe methods, the majority of European laboratories are still using these methods [1] . It is of crucial importance that Jaffe methods are replaced by enzymatic assays, to further prevent patient harm. We therefore hereby repeat our former recommendation to laboratory specialists and manufacturers to take their responsibility and to implement exclusively creatinine tests that are fitfor-clinical-purpose [1, 4] .
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The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication. ) and deviations in eGFR (%, colored background) based on creatinine measurements using Jaffe and enzymatic methods of Abbott, Beckman-Coulter, Roche and Siemens at glucose concentrations ranging from 0 to 30 mmol/L and total protein concentrations ranging from 30 to 100 g/L.
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